AZTHERAPIES, INC

Profile

Company Names

AZTHERAPIES, INC

Addresses

200 CLARENDON STREET, 17TH FLOOR, BOSTON, MA 02116

222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA 02116

501 BOYLSTON STREET, SUITE 6102, BOSTON, MA 02116

500 BOYLSTON STREET, SUITE 1600, BOSTON, MA 02116

Phone Numbers

617-318-3411
617-784-0490
617-482-2333

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$85,814,494.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2020-08-28 
$14,825,487.00 
$35,000,000.00 
$20,174,513.00 
Equity 
7
2019-06-28 
$19,040,284.00 
$37,500,000.00 
$18,459,716.00 
Equity 
6
2019-05-16 
$5,608,027.00 
$7,500,000.00 
$1,891,973.00 
Debt 
5
2018-06-18 
$16,060,491.00 
$25,473,350.00 
$9,412,859.00 
Equity 
4
2017-12-01 
$1,570,000.00 
$6,000,000.00 
$4,430,000.00 
Debt 
3
2017-06-16 
$6,549,969.00 
$7,600,000.00 
$1,050,031.00 
 
2
2015-11-20 
$16,050,236.00 
$20,000,000.00 
$3,949,764.00 
Equity 
1
2014-12-22 
$6,110,000.00 
$13,000,000.00 
$6,890,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
BARTLETT 
EXECUTIVE OFFICER
NANOTOMER, INC.   |  AZTHERAPIES, INC
GEORGE 
 
BEHRAKIS 
DIRECTOR
AZTHERAPIES, INC
GEORGE 
T. 
BEHRAKIS 
DIRECTOR
AZTHERAPIES, INC
PETER 
 
CONTI 
DIRECTOR
FLUOROPHARMA MEDICAL, INC.   |  AZTHERAPIES, INC   |  NANOTOMER, INC.
DAVID 
 
ELMALEH 
EXECUTIVE OFFICER, DIRECTOR
MATRITEK, INC.   |  AZTHERAPIES, INC
DAVID 
R 
ELMALEH 
EXECUTIVE OFFICER, DIRECTOR
AZTHERAPIES, INC
DAVID 
R. 
ELMALEH 
EXECUTIVE OFFICER, DIRECTOR
FLUOROPHARMA MEDICAL, INC.   |  AZTHERAPIES, INC   |  NANOTOMER, INC.
DAVID 
R.. 
ELMALEH 
EXECUTIVE OFFICER, DIRECTOR
AZTHERAPIES, INC
NOAH 
 
GOTTDIENER 
DIRECTOR
DEERFIELD TOPCO CORP   |  DEERFIELD HOLDINGS CORP   |  FOCUS FINANCIAL PARTNERS INC.   |  D+P US HOLDING CORP   |  AZTHERAPIES, INC   |  GO, INC.   |  DELTA PARENT HOLDINGS, INC.
KEITH 
 
GREENFIELD 
EXECUTIVE OFFICER, DIRECTOR
IQUUM INC   |  AZTHERAPIES, INC   |  NANOTOMER, INC.   |  GENERAL FLUIDICS CORP   |  CYMON BIO, INC.
JAY 
 
MOHR 
EXECUTIVE OFFICER
AZTHERAPIES, INC   |  MESENTECH INC.
THIERRY 
 
PORTE 
DIRECTOR
AZTHERAPIES, INC   |  ACTA PHARMACEUTICALS, INC.   |  LMAX EXCHANGE GROUP LTD
JOHN 
 
PORTER 
DIRECTOR
DECISIONLINK CORP   |  AZTHERAPIES, INC   |  PHOSPLATIN THERAPEUTICS LLC   |  PILOSA CORP.   |  MOLECULA CORP.   |  SAVI SOLUTION, INC.
KAREN 
 
REEVES 
EXECUTIVE OFFICER
AZTHERAPIES, INC
GILLIAN 
 
SANDLER 
DIRECTOR
AZTHERAPIES, INC   |  COSINE-AZT INVESTORS, LLC   |  MYMEE INC.
DAVID 
 
TAFT 
DIRECTOR
IQUUM INC   |  XOLVE, INC.   |  AZTHERAPIES, INC   |  APPLIED MINERALS, INC.
RONALD 
 
TOMPKINS 
DIRECTOR
EYE INVESTMENT FUND LTD.   |  AZTHERAPIES, INC   |  MICROMEDICINE, INC.   |  GENERAL FLUIDICS CORP
ROBERT 
S. 
WARREN 
EXECUTIVE OFFICER
AZTHERAPIES, INC   |  FNL TECHNOLOGIES, INC.   |  NANOTOMER, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-09-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-28 
2019-07-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
2019-05-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-05-16 
2018-10-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-18 
2018-07-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-18 
2017-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-12-01 
2017-11-15
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
 
2017-06-16 
2017-06-30
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
 
2017-06-16 
2017-02-06
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2015-11-20 
2015-12-07
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2015-11-20 
2015-01-06
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2014-12-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#